Chiron Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Chiron Capital Management's PFE Position: Q1 2026 in Review
Chiron Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 59,126 shares worth $1.66M. The stake represents 1.7% of the portfolio and ranks #12 among its holdings. This is a return to the name: Chiron Capital Management previously reported a position in PFE as recently as Q3 2025.
Chiron Capital Management first reported a position in PFE in Q3 2020 and has held it in 22 quarters since. The position peaked at $5.57M in Q1 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Chiron Capital Management held 59,126 shares of Pfizer worth $1.66M as of Q1 2026.
- Pfizer was a new Chiron Capital Management position in Q1 2026.
- Pfizer made up 1.7% of Chiron Capital Management's portfolio in Q1 2026, its #12 holding.
- Chiron Capital Management first reported a position in Pfizer in Q3 2020 and has held it in 22 quarters since.
- Chiron Capital Management's Pfizer position peaked at $5.57M in Q1 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Chiron Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.